Skip to main content
Clinical Trials/NL-OMON55406
NL-OMON55406
Completed
N/A

Cognitive functioning and health-related quality of life in long-term anaplastic oligondendroglioma and oligoastrocytoma survivors from the EORTC 26951 study: second follow-up - Follow-up of anaplastic oligondendroglioma and oligoastrocytoma patients

Haaglanden Medisch Centrum0 sites12 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
oligondendroglioma/oligoastrocytoma
Sponsor
Haaglanden Medisch Centrum
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 4, 2020
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients are eligible for participation if they meet the following criteria:
  • 1\) They are diagnosed with an anaplastic oligodendroglioma or oligoastrocytoma;
  • 2\) They are adults; over 18 years old;
  • 3\) They participated in EORTC 26951 study and the first follow\-up study;
  • 4\) They have signed the informed consent form, or, when unable to decide, their
  • legal representative signed the informed consent form for their participation
  • and the use of their data., Proxies are eligible for participation if they meet
  • the following criteria:
  • 1\) The patient is not deemed able to participate (as judged by the treating
  • physician) due to a poor physical or mental condition;

Exclusion Criteria

  • Patients are not considered eligible for study participation if:
  • 1\) They are not eligible for participating in the study according to the
  • treating physician, due to severe physical or mental impairments hampering
  • filling in the questionnaires or undergoing the cognitive tests;
  • 2\) They are unable to communicate adequately., Proxies are not considered
  • eligible for study participation if:
  • 1\) They are unable to communicate adequately;
  • 2\) The patient, or his/her legal representative, has not signed the informed
  • consent form for proxy participation;
  • 3\) They proxy him\- or herself has not signed his/her own informed consent form.

Outcomes

Primary Outcomes

Not specified

Similar Trials